Bantas, Acas M.

HRN: 04-41-37  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2024
CEFTRIAXONE 1G (VIAL)
02/02/2024
02/09/2024
IV
2g
Q24
Abdominal Mass
Waiting Final Action 
02/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2024
02/09/2024
IV
500mg
Q8
Abdominal Mass
Waiting Final Action 
02/06/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/06/2024
02/13/2024
IV
2.25gm
Q6H
Abdominal Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: